ENZYME

European patent · EP2563913 · In force

Register entry

Publication number
EP2563913
Application number
EP11731447
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 14, 2011
Published
Mar 6, 2013
Granted
Jun 6, 2018
Protection ends at the latest
Apr 13, 2031
Next annual fee due
Apr 30, 2027
IPC classes
C12N 9/10 (2006.01)
Priority
US 396008 P 20.05.2010
GB 201007384 30.04.2010
PCT application
PCT/GB2011/000583 14.04.2011
PCT publication
WO2011/135280 03.11.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Jul 25, 2018

    Owner

    Owner
    Medical Research Council, 2nd Floor, David Phillips Building, Polaris House, North Star Avenue, Swindon SN2 1FL, United Kingdom → United Kingdom Research and Innovation, Polaris House, North Star Avenue, Swindon SN2 1FL, United Kingdom

    Published in Swissreg on 25.07.2018

  6. Jun 6, 2018

    Granted

    Published in Swissreg on 06.06.2018

Parties

Holder

United Kingdom Research and Innovation

Swindon SN2 1FL, GB

Inventor

HOLLIGER, Philipp

Cambridge CB2 0QH, GB

COZENS, Christopher

Cambridge CB2 0QH, GB

PINHEIRO, Vitor B.

London WC1E 6BT, GB

TAYLOR, Alexander I.

Cambridge CB2 0QH, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.